Influenza in High-Risk Patients: Aching for Optimal Treatment

Program Overview

In this activity, a panel of experts discusses therapeutic options for influenza and reasons why influenza treatment is commonly overlooked even in high-risk patients. Challenges in diagnosing and treating influenza in the era of COVID-19 are highlighted. A high-risk experienced influenza patient shares her experiences with diagnosis and treatment and how influenza affected her quality of life.

Credit Expired

Target Audience

This activity is intended for emergency medicine, infectious disease, and primary care clinicians involved in the treatment of patients with influenza.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Identify patients who may be at high risk for influenza-related complications
Recognize the possible presentations of influenza in high-risk individuals
Assess key data available for antiviral therapies for post-exposure chemoprophylaxis and treatment of influenza in high-risk individuals
Recommend an appropriate antiviral agent for post-exposure chemoprophylaxis or treatment of influenza in high-risk patients with influenza

Activity Faculty

Michael G. Ison, MD, MS

Medical Director, Transplant & Immunocompromised Host Infectious Diseases Service
Northwestern University Comprehensive Transplant Center
Northwestern University Feinberg School of Medicine
Chicago, IL

Christopher J. Coyne, MD, MPH

Director, Clinical Research Department of Emergency Medicine
University of California San Diego
San Diego, CA

Richard K. Zimmerman, MD, MPH, MS

Professor, Department of Family Medicine
University of Pittsburgh School of Medicine
Pittsburgh, PA

Featured RMEI CE Activities – Earn CE Credit(s)

Influenza in High-Risk Patients: Aching for Optimal Treatment

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Michael G. Ison, MD, MS

Christopher J. Coyne, MD, MPH

Richard K. Zimmerman, MD, MPH, MS

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe